Patents by Inventor Xueyun Jiang

Xueyun Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10806798
    Abstract: The present invention discloses a novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting, as well as a preparation method and use thereof. The compound is a ternary conjugate formed by conjugating a thrombolytic peptide, a free radical scavenger and a thrombus-targeting/antithrombotic peptide together via a linking arm. The present invention also discloses a pharmaceutical composition containing the compounds, wherein the compounds form a nanospherical structure.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: October 20, 2020
    Assignee: Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Shiqi Peng, Ming Zhao, Xueyun Jiang
  • Publication number: 20180264126
    Abstract: The present invention discloses a novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting, as well as a preparation method and use thereof. The compound is a ternary conjugate formed by conjugating a thrombolytic peptide, a free radical scavenger and a thrombus-targeting/antithrombotic peptide together via a linking arm. The present invention also discloses a pharmaceutical composition containing the compounds, wherein the compounds form a nanospherical structure.
    Type: Application
    Filed: May 29, 2018
    Publication date: September 20, 2018
    Inventors: Shiqi PENG, Ming ZHAO, Xueyun JIANG
  • Publication number: 20150290339
    Abstract: The present invention discloses a novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting, as well as a preparation method and use thereof. The compound is a ternary conjugate formed by conjugating a thrombolytic peptide, a free radical scavenger and a thrombus-targeting/antithrombotic peptide together via a linking arm. The present invention also discloses a pharmaceutical composition containing the compounds, wherein the compounds form a nanospherical structure.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 15, 2015
    Inventors: Shiqi Peng, Ming Zhao, Xueyun Jiang